Suppr超能文献

美国病理学家学会在美国的调查参与者中对流感嗜血杆菌进行的体外药敏试验实践。

In vitro susceptibility test practices with Haemophilus influenzae among College of American Pathologists survey participants in the United States.

作者信息

Doern G V, Jones R N

机构信息

Department of Clinical Microbiology, University of Massachusetts Medical Center, Worcester 01655.

出版信息

Diagn Microbiol Infect Dis. 1993 Jul;17(1):61-5. doi: 10.1016/0732-8893(93)90072-f.

Abstract

Questionnaire results from 5233 clinical microbiology laboratories participating in the College of American Pathologists (CAP) survey program in the United States were used to establish current standards of practice with respect to in vitro susceptibility testing of Haemophilus influenzae. The results of this CAP survey indicated that the recently developed National Committee for Clinical Laboratory Standards (NCCLS) guidelines for H. influenzae susceptibility tests have been widely adopted, particularly with regard to the medium used to perform susceptibility tests. Haemophilus test medium (HTM) is now the most commonly used medium and there exists a general level of satisfaction (approximately 80%) with medium performance. Specific methodologic recommendations of the NCCLS, however, are often not being followed, for example, length and atmosphere of incubation and means of preparing inocula. beta-Lactamase assays constitute a very commonly employed means of assessing ampicillin activity. Among susceptibility test methods, disk diffusion (82.2%) is much more commonly used compared with broth microdilution (17.8%) procedures. Data are provided regarding the most commonly tested antimicrobials as well as some of the problems encounted when using current NCCLS methods for susceptibility tests with H. influenzae. Finally, the CAP survey questionnaire revealed that many laboratories have applied HTM to susceptibility tests with other fastidious bacteria such as pathogenic Neisseria sp., streptococci, and Moraxella catarrhalis.

摘要

美国5233家参与美国病理学家学会(CAP)调查项目的临床微生物实验室的调查问卷结果,被用于确立流感嗜血杆菌体外药敏试验的现行操作标准。CAP调查结果表明,美国国家临床实验室标准委员会(NCCLS)最近制定的流感嗜血杆菌药敏试验指南已被广泛采用,尤其是在用于进行药敏试验的培养基方面。嗜血杆菌试验培养基(HTM)现在是最常用的培养基,并且对培养基性能总体满意度约为80%。然而,NCCLS的具体方法学建议常常未被遵循,例如孵育时间、孵育环境和接种物制备方法。β-内酰胺酶检测是评估氨苄西林活性非常常用的方法。在药敏试验方法中,纸片扩散法(82.2%)比肉汤微量稀释法(17.8%)使用更为普遍。文中提供了关于最常检测的抗菌药物的数据,以及在使用现行NCCLS方法进行流感嗜血杆菌药敏试验时遇到的一些问题。最后,CAP调查问卷显示,许多实验室已将HTM用于对其他苛养菌如致病性奈瑟菌属细菌、链球菌和卡他莫拉菌的药敏试验。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验